Development of novel gene medicine for rheumatoid arthritis
Project/Area Number |
23790186
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Medical pharmacy
|
Research Institution | Nagasaki University |
Principal Investigator |
KODAMA Yukinobu 長崎大学, 医歯(薬)学総合研究科, 助教 (50448510)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 遺伝子デリバリー / 関節リウマチ / メトトレキセート / コンドロイチン硫酸 / メトトレキサート |
Research Abstract |
In this study, we developed the novel delivery system which enables delivery of both gene and drugs to rheumatoid arthritis. We successfully prepared the pDNA-PEI-MTX complexes (MTX complexes) by optimization of the mix ratio and preparation process. MTX complexes showed high gene expression in human fibroblast-like synoviocytes from RA patients (HFLS-RA). We also developed siRNA-PEI-CS (CS complexes). CS complexes showed high silencing effect comparable to commercial vector (lipofectamine).
|
Report
(4 results)
Research Products
(17 results)
-
-
[Journal Article] Ternary complex of plasmid DNA with protamine andγ-polyglutamic acid for biocompatible gene delivery system2013
Author(s)
Kanda K, Kodama Y, Kurosaki T, Imamura M, Nakagawa H, Muro T, Higuchi N, Nakamura T, Kitahara T, Honda M, Sasaki H
-
Journal Title
Biol Pharm Bull
Volume: 36(11)
Pages: 1794-9
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-